{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:35:27Z","timestamp":1792445727718,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP1\/132\/46"],"award-info":[{"award-number":["RGP1\/132\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109790","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:06:20Z","timestamp":1774512380000},"page":"109790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Isatin-triazole\/imidazole hybrids as dual CDK2\/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluations"],"prefix":"10.1016","volume":"175","author":[{"given":"Zainab M.","family":"Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Balaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham O.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman F.","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz A.","family":"Shaldam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T.","family":"Negmeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada H.","family":"Al-Ansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaaeldin M.","family":"Elimam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"di Giacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109790_bb0005","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109790_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.109790_bb0015","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.3390\/molecules25204606","article-title":"Significance of targeting VEGFR-2 and cyclin D1 in luminal-a breast cancer","volume":"25","author":"Abdalla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109790_bb0020","first-page":"3285","article-title":"Discovery of new potential CDK2\/VEGFR2 type II inhibitors by fragmentation and virtual screening of natural products","volume":"39","author":"V\u00e1squez","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.109790_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109790_bb0030","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/cells10123327","article-title":"Regulation of cell cycle progression by growth factor-induced cell signaling","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109790_bb0035","article-title":"Molecular bases of VEGFR-2-mediated physiological function and pathological role","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.109790_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1331064","article-title":"Angiogenesis in nasopharyngeal carcinoma: insights, imaging, and therapeutic strategies","volume":"14","author":"Xia","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.109790_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ardp.201400337","article-title":"Design, synthesis and in vitro antiproliferative activity of novel Isatin-quinazoline hybrids","volume":"348","author":"Fares","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.109790_bb0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14728222.2025.2537412","article-title":"Targeting CDK2 and other novel cell cycle targets for breast cancer therapy","volume":"29","author":"Chen","year":"2025","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2026.109790_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400411","article-title":"Design, synthesis, and biological evaluation of naphthalene imidazo [1, 2-b] pyridazine hybrid derivatives as VEGFR selective inhibitors","volume":"357","author":"Wang","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.109790_bb0060","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1055\/s-0044-1789577","article-title":"Recent development of CDK2 inhibitors as anticancer drugs: an update (2015\u20132023)","volume":"6","author":"Jin","year":"2024","journal-title":"Pharmaceut. Fronts"},{"key":"10.1016\/j.bioorg.2026.109790_bb0065","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.3390\/cancers17203354","article-title":"Repurposing the tyrosine kinase inhibitors targeting FGFR and VEGFR pathways for cancer therapy: a comprehensive review","volume":"17","author":"Boichuk","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109790_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113083","article-title":"Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold","volume":"211","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111366","article-title":"Novel nano-sized N-Thiazolylpyridylamines targeting CDK2: design, divergent synthesis, conformational studies, and multifaceted in silico analysis","volume":"407","author":"Bondock","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.109790_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109057","article-title":"Innovative design and synthesis of dual-acting hCA IX\/CDK-2 inhibitors through hetero ring fused pyrimidine utilization for cutting-edge anticancer therapy: zein nanoparticles for in vivo lung cancer treatment","volume":"166","author":"Abosalim","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0085","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1021\/acsmedchemlett.4c00438","article-title":"Furan- and Furopyrimidine-Based Derivatives: Synthesis, VEGFR-2 Inhibition, and In Vitro Cytotoxicity","volume":"15","author":"Abd El-Haleem","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109790_bb0090","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1002\/slct.202101367","article-title":"Correlation analysis of target selectivity and side effects of FDA-approved kinase inhibitors","volume":"6","author":"Bayazeid","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109790_bb0095","series-title":"Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy","first-page":"443","article-title":"Chapter 17 - vascular endothelial growth factor receptors (VEGFR\/PDGFR) inhibitors","author":"Elgawish","year":"2024"},{"key":"10.1016\/j.bioorg.2026.109790_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107703","article-title":"Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors","volume":"151","author":"Sabt","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0105","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1039\/c4ob00496e","article-title":"Studies on the stereochemical assignment of 3-acylidene 2-oxindoles","volume":"12","author":"Edeson","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0110","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41598-024-82005-6","article-title":"Design and synthesis of antiproliferative 2-oxoindolin-3-ylidenes incorporating urea function with potential VEGFR-2 inhibitory properties","volume":"15","author":"Aboshouk","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109790_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105436","article-title":"Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents","volume":"166","author":"Xu","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2026.109790_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70190","article-title":"Leveraging the fragment merging approach for synthetizing novel Selanyl phenyl acetamide thiazolidinedione hybrids endowed with apoptotic potential for Cancer treatment","volume":"86","author":"Shaaban","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.109790_bb0125","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.3390\/molecules27154912","article-title":"Pyrimidines-based heterocyclic compounds: synthesis, Cytoxicity evaluation and molecular docking","volume":"27","author":"El-Atawy","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109790_bb0130","doi-asserted-by":"crossref","first-page":"31527","DOI":"10.1038\/s41598-025-17260-2","article-title":"Synthesis and computational investigation of novel 2-mercaptoimidazolones as dual antimicrobial and anti-proliferative agents with potential multitargeting kinase inhibitory activity","volume":"15","author":"Ali","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109790_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107581","article-title":"Discovery of colchicine aryne cycloadduct as a potent molecule for the abrogation of epithelial to mesenchymal transition via modulating cell cycle regulatory CDK-2 and CDK-4 kinases in breast cancer cells","volume":"150","author":"Iqbal Lone","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0140","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109790_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14503","article-title":"Flubendazole suppresses VEGF-induced angiogenesis in HUVECs and exerts antitumor effects in PC-3 cells","volume":"103","author":"Zhang","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.109790_bb0150","first-page":"803","article-title":"Anti-breast cancer potential of thieno-pyrimidine derivatives as VEGFR-2 inhibitors, future","volume":"17","author":"Alsfouk","year":"2025","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116140","article-title":"Targeting CDK2 for cancer therapy","volume":"44","author":"Knudsen","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.109790_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10822-025-00599-z","article-title":"Anticancer potential of novel benzothiazolyl piperidine-3-carboxamide derivatives as CDKs and VEGFR2 multi-target kinase inhibitors","volume":"39","author":"Afzal","year":"2025","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2026.109790_bb0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1134\/S1068162024010230","article-title":"Novel bipyrazole targeting dual CDK-2 and VEGFR-2 kinases: synthesis, anticancer evaluation, and in silico studies, Russian journal of","volume":"50","author":"Nossier","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0170","first-page":"1","article-title":"Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repair","author":"Liu","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.bioorg.2026.109790_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.31083\/j.fbl2708238","article-title":"Endostar synergizes with radiotherapy to inhibit angiogenesis of cervical cancer in a subcutaneous xenograft mouse model","volume":"27","author":"Xu","year":"2022","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.bioorg.2026.109790_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108494","article-title":"Novel benzofuran-conjugated indolin-2-ones as anticancer agents; design, synthesis, biological assessments, and molecular modeling insights","volume":"160","author":"Eldehna","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0185","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejmech.2018.12.026","article-title":"Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis","volume":"163","author":"Aneja","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0190","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1021\/jm010117d","article-title":"Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis","volume":"44","author":"Bramson","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0195","first-page":"5201374","article-title":"Synthesis of novel 1, 2, 4-triazolyl coumarin derivatives as potential anticancer agents","volume":"2018","author":"Al-Wahaibi","year":"2018","journal-title":"J. Chemother."},{"key":"10.1016\/j.bioorg.2026.109790_bb0200","series-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","first-page":"18281","volume":"109","author":"McTigue","year":"2012"},{"key":"10.1016\/j.bioorg.2026.109790_bb0205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1039\/D5MD01043H","article-title":"Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2\/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitization","volume":"17","author":"Eldehna","year":"2026","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109071","article-title":"Identification of isatin-triazole-benzenesulfonamide hybrids as dual hCA IX\/XII and c-met inhibitors with hypoxia-mediated chemo-sensitizing activity","volume":"166","author":"Eldehna","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0215","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/pharmaceutics12090838","article-title":"Biological evaluation of black chokeberry extract free and embedded in two mesoporous silica-type matrices","volume":"12","author":"Buda","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.109790_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137753","article-title":"Biological and computational assessment of new synthesized nicotinamides as potential immunomodulatory VEGFR-2 inhibitors","volume":"1305","author":"Yousef","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109790_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300599","article-title":"Phthalimide-tethered isatins as novel poly (ADP-ribose) polymerase inhibitors: design, synthesis, biological evaluations, and molecular modeling investigations","volume":"357","author":"El Hassab","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.109790_bb0230","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1080\/14756366.2022.2110869","article-title":"New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies","volume":"37","author":"Elkaeed","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0235","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","article-title":"1,5-Diaryl-1,2,4-triazole Ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities","volume":"66","author":"Elsawi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0240","doi-asserted-by":"crossref","first-page":"107626","DOI":"10.1016\/j.bioorg.2024.107626","article-title":"Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2\/STAT-3 inhibitors: design, synthesis and biological assessments","volume":"151","author":"Elsebaie","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0245","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1039\/D4MD00280F","article-title":"Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies","volume":"15","author":"Elsebaie","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0250","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","article-title":"Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, in vitro, in vivo, and in silico investigations of coumarin-based thiazoles","volume":"67","author":"Hefny","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138148","article-title":"Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: synthesis, biological assessment, and molecular dynamic simulations","volume":"1309","author":"Shaldam","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109790_bb0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/odi.15120","article-title":"Cold atmospheric plasma activated media selectively affects human head and neck cancer cell lines","volume":"31","author":"di Giacomo","year":"2025","journal-title":"Oral Dis."},{"key":"10.1016\/j.bioorg.2026.109790_bb0265","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/acs.jmedchem.3c01708","article-title":"Lead optimization of BIBR1591 to improve its telomerase inhibitory activity: design and synthesis of novel four chemical series with in silico, in vitro, and in vivo preclinical assessments","volume":"67","author":"Al-Karmalawy","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2021.105173","article-title":"Synthesis, antitubercular, antimicrobial activities and molecular docking study of quinoline bearing dihydropyrimidines","volume":"115","author":"Desai","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0275","first-page":"1651","article-title":"Exploring Pyrazoline-Thiophene Hybrids as CDK2 Inhibitors: Synthesis, Mechanistic","volume":"17","author":"Abosalim","year":"2026","journal-title":"Biological Studies, and Computational Insights, RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0280","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0285","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.3390\/ijms262311398","article-title":"Structure-based design and in silico evaluation of a lipophilic Cyclooctanoyl-derivative as a renin inhibitor: lessons from withdrawn Aliskiren","volume":"26","author":"Pavlos","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109790_bb0290","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1016\/j.bmcl.2010.06.157","article-title":"X-ray crystal structure of JNK2 complexed with the p38\u03b1 inhibitor BIRB796: insights into the rational design of DFG-out binding MAP kinase inhibitors","volume":"20","author":"Kuglstatter","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109790_bb0295","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel pyridazine-tethered Sulfonamides as carbonic anhydrase II inhibitors for the Management of Glaucoma","volume":"67","author":"Tawfik","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0305","first-page":"1440","article-title":"C-Jun N-terminal kinase inhibitors: structural insight into kinase-inhibitor complexes, computational and structural","volume":"18","author":"Duong","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bioorg.2026.109790_bb0310","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.3390\/molecules28083358","article-title":"Computational exploration of Licorice for Lead compounds against plasmodium vivax Duffy binding protein utilizing molecular docking and molecular dynamic simulation","volume":"28","author":"Yasir","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109790_bb0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.109790_bb0320","series-title":"CHARMM: The biomolecular simulation program","first-page":"1545","volume":"vol. 30","author":"Brooks","year":"2009"},{"key":"10.1016\/j.bioorg.2026.109790_bb0325","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1080\/07391102.2021.1936178","article-title":"Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2","volume":"40","author":"Sharma","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.109790_bb0330","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109790_bb0335","article-title":"Molecular dynamics simulation of bulk nanobubbles","volume":"650","author":"Hewage","year":"2022","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bioorg.2026.109790_bb0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.bioorg.2026.109790_bb0345","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/bbb\/zbaa024","article-title":"Effects of side chain length of 10-methyl-aplog-1, a simplified analog of debromoaplysiatoxin, on PKC binding, anti-proliferative, and pro-inflammatory activities","volume":"85","author":"Gonda","year":"2021","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"33\u201338","key":"10.1016\/j.bioorg.2026.109790_bb0350","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.bioorg.2026.109790_bb0355","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:49:11Z","timestamp":1778701751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":71,"alternative-id":["S0045206826003263"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109790","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isatin-triazole\/imidazole hybrids as dual CDK2\/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluations","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109790"}}